keyword
https://read.qxmd.com/read/36823241/impact-of-reboxetine-plus-oxybutynin-treatment-for-obstructive-sleep-apnea-on-cardiovascular-autonomic-modulation
#21
JOURNAL ARTICLE
Elisa Perger, Paolo Castiglioni, Andrea Faini, Davide Soranna, Antonella Zambon, Debora Rosa, Stefano Vicini, Paolo Meriggi, Laura Pini, Claudia Baratto, Sergio Caravita, Ali Azarbarzin, Gianfranco Parati, Carolina Lombardi
The combination of noradrenergic (reboxetine) plus antimuscarinic (oxybutynin) drugs (reb-oxy) reduced obstructive sleep apnea (OSA) severity but no data are available on its effects on cardiac autonomic modulation. We sought to evaluate the impact of 1-week reb-oxy treatment on cardiovascular autonomic control in OSA patients. OSA patients were randomized to a double-blind, crossover trial comparing 4 mg reboxetine plus 5 mg oxybutynin to a placebo for OSA treatment. Heart rate (HR) variability (HRV), ambulatory blood pressure (BP) monitoring (ABPM) over 24 h baseline and after treatment were performed...
February 23, 2023: Scientific Reports
https://read.qxmd.com/read/36638092/tramadol-regulates-the-activation-of-human-platelets-via-rac-but-not-rho-rho-kinase
#22
JOURNAL ARTICLE
Hiroki Iida, Takashi Onuma, Daiki Nakashima, Daisuke Mizutani, Takamitsu Hori, Kyohei Ueda, Tomoyuki Hioki, Woo Kim, Yukiko Enomoto, Tomoaki Doi, Rie Matsushima-Nishiwaki, Shinobu Yamaguchi, Junko Tachi, Kumiko Tanabe, Shinji Ogura, Toru Iwama, Osamu Kozawa, Haruhiko Tokuda
Tramadol is a useful analgesic which acts as a serotonin and noradrenaline reuptake inhibitor in addition to μ-opioid receptor agonist. Cytoplasmic serotonin modulates the small GTPase activity through serotonylation, which is closely related to the human platelet activation. We recently reported that the combination of subthreshold collagen and CXCL12 synergistically activates human platelets. We herein investigated the effect and the mechanism of tramadol on the synergistic effect. Tramadol attenuated the synergistically stimulated platelet aggregation (300 μM of tramadol, 64...
2023: PloS One
https://read.qxmd.com/read/36449401/meta-analysis-on-the-efficacy-of-the-norepinephrine-reuptake-inhibitors-reboxetine-and-atomoxetine-for-the-treatment-of-schizophrenia-and-attention-deficit-hyperactivity-disorder
#23
JOURNAL ARTICLE
Xiaojing Hu, Lili Pan, Wenjie Li
BACKGROUND: Norepinephrine transporter inhibitors that can alter the level of neurotransmitter in the brain are used to treat neurological disorders. However, a number of studies have reported their limited significance as a result of their slow onset of action and moderate efficacy. OBJECTIVES: To determine the effects of norepinephrine reuptake inhibitors (NRIs), reboxetine and atomoxetine on schizophrenia and attention deficit hyperactivity disorder (ADHD). MATERIAL AND METHODS: Relevant articles published between 2000 and 2022 were searched in the MEDLINE, CINAHL (via Ebsco), Web of Science and Scopus databases...
November 30, 2022: Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University
https://read.qxmd.com/read/36448969/monoaminergic-mediation-of-hyperalgesic-and-analgesic-descending-control-of-nociception-in-mice
#24
JOURNAL ARTICLE
Wataru Nemoto, Dalia Kozak, Susana G Sotocinal, Shannon Tansley, Kirsty Bannister, Jeffrey S Mogil
Descending control of nociception (DCN; also known as conditioned pain modulation [CPM], the behavioral correlate of diffuse noxious inhibitory controls) is the phenomenon whereby pain inhibits pain in another part of the body and is the subject of increasing study because it may represent a biomarker of chronic pain. We recently discovered that pain modulation on the application of a DCN paradigm involving low-intensity test stimuli occurs in the direction of hyperalgesia in healthy mice and rats, whereas the use of high-intensity stimuli produces analgesia...
May 1, 2023: Pain
https://read.qxmd.com/read/36386987/risk-to-befit-ratios-of-consecutive-antidepressants-for-heavy-menstrual-bleeding-in-young-women-with-bipolar-disorder-or-major-depressive-disorder
#25
JOURNAL ARTICLE
Chuanjun Zhuo, Guangdong Chen, Chongguang Lin, Jing Ping, Jingjing Zhu, Lina Wang, Shili Jin, Chuanxin Liu, Qiuyu Zhang, Lei Yang, Qianchen Li, Chunhua Zhou, Langlang Cheng, Hongjun Tian, Xueqin Song
The occurrence of heavy menstrual bleeding (HMB) induced by pharmacological agents has been reported in young adult women. This study aimed to investigate a possible association between the occurrence rates of HMB and different treatment methods such as antidepressant agents alone and in combination with other pharmacological agents. The examined cohort included young women (age 18-35 years, n = 1,949) with bipolar disorder (BP) or major depressive disorder (MDD). Menstruation history for 24 months was recorded and evaluated according to pictorial blood loss assessment charts of HMB...
2022: Frontiers in Psychiatry
https://read.qxmd.com/read/36292306/pharmacotherapy-for-obstructive-sleep-apnoea-and-coupled-life-a-descriptive-phenomenological-study-of-a-complex-interaction
#26
JOURNAL ARTICLE
Debora Rosa, Elisa Perger, Giulia Villa, Loris Bonetti, Valeria Storti, Elisa Cartabia, Giuseppina Ledonne, Carolina Lombardi, Albanesi Beatrice, Carla Amigoni, Gianfranco Parati
BACKGROUND: Obstructive Sleep Apnoea (OSA) is a common chronic sleep-related breathing disorder. Drug therapy is a recent approach to treating OSA, and no data is available regarding its effects on a couple's life. The aim of this study was to investigate the impact on couples' lives of a novel drug treatment for OSA. METHODS: Participants of a trial on new drug therapy (reboxetine plus oxybutynin) for OSA were interviewed. The study was conducted using a descriptive phenomenological approach by Sundler et al...
September 24, 2022: Healthcare (Basel, Switzerland)
https://read.qxmd.com/read/36278185/comorbid-epilepsy-and-depression-pharmacokinetic-and-pharmacodynamic-drug-interactions
#27
REVIEW
Barbara Miziak, Stanisław J Czuczwar, Ryszard Pluta
Background: Major depressive disorder may be encountered in 17% of patients with epilepsy and in patients with drug-resistant epilepsy its prevalence may reach 30%. This indicates that patients with epilepsy may require antidepressant treatment. Purpose: Both pharmacodynamic and pharmacokinetic interactions between antiepileptic (antiseizure) and antidepressant drugs have been reviewed. Also, data on the adverse effects of co-administration of antiepileptic with antidepressant drugs have been added. This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology...
2022: Frontiers in Pharmacology
https://read.qxmd.com/read/36253442/antidepressants-for-the-treatment-of-adults-with-major-depressive-disorder-in-the-maintenance-phase-a-systematic-review-and-network-meta-analysis
#28
Taro Kishi, Toshikazu Ikuta, Kenji Sakuma, Makoto Okuya, Masakazu Hatano, Yuki Matsuda, Nakao Iwata
A systematic review and random-effects model network meta-analysis were conducted to compare the efficacy, acceptability, tolerability, and safety of antidepressants to treat adults with major depressive disorder (MDD) in the maintenance phase. This study searched the PubMed, Cochrane Library, and Embase databases and included only double-blind, randomized, placebo-controlled trials with an enrichment design: patients were stabilized on the antidepressant of interest during the open-label study and then randomized to receive the same antidepressant or placebo...
January 2023: Molecular Psychiatry
https://read.qxmd.com/read/36209771/fast-antidepressant-action-of-ketamine-in-mouse-models-requires-normal-vglut1-levels-from-prefrontal-cortex-neurons
#29
JOURNAL ARTICLE
Francisco de Borja Belloch, María Cortés-Erice, Etienne Herzog, Xiao Min Zhang, Teresa Díaz-Perdigon, Elena Puerta, Rosa M Tordera
The NMDA antagonist ketamine demonstrated a fast antidepressant activity in treatment-resistant depression. Pre-clinical studies suggest that de novo synthesis of the brain-derived neurotrophic factor (BDNF) in the PFC might be involved in the rapid antidepressant action of ketamine. Applying a genetic model of impaired glutamate release, this study aims to further identify the molecular mechanisms that could modulate antidepressant action and resistance to treatment. To that end, mice knocked-down for the vesicular glutamate transporter 1 (VGLUT1+/-) were used...
October 6, 2022: Progress in Neuro-psychopharmacology & Biological Psychiatry
https://read.qxmd.com/read/36190739/pharmacological-interventions-for-prevention-of-weight-gain-in-people-with-schizophrenia
#30
REVIEW
Sri Mahavir Agarwal, Nicolette Stogios, Zohra A Ahsan, Jonathan T Lockwood, Markus J Duncan, Hiroyoshi Takeuchi, Tony Cohn, Valerie H Taylor, Gary Remington, Guy E J Faulkner, Margaret Hahn
BACKGROUND: Antipsychotic-induced weight gain is an extremely common problem in people with schizophrenia and is associated with increased morbidity and mortality. Adjunctive pharmacological interventions may be necessary to help manage antipsychotic-induced weight gain. This review splits and updates a previous Cochrane Review that focused on both pharmacological and behavioural approaches to this problem. OBJECTIVES: To determine the effectiveness of pharmacological interventions for preventing antipsychotic-induced weight gain in people with schizophrenia...
October 3, 2022: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/36175479/monoamine-control-of-descending-pain-modulation-after-mild-traumatic-brain-injury
#31
JOURNAL ARTICLE
Peyman Sahbaie, Karen-Amanda Irvine, Xiao-You Shi, J David Clark
Traumatic brain injury (TBI) is a significant public health concern, with the majority of injuries being mild. Many TBI victims experience chronic pain. Unfortunately, the mechanisms underlying pain after TBI are poorly understood. Here we examined the contribution of spinal monoamine signaling to dysfunctional descending pain modulation after TBI. For these studies we used a well-characterized concussive model of mild TBI. Measurements included mechanical allodynia, the efficacy of diffuse noxious inhibitory control (DNIC) endogenous pain control pathways and lumber norepinephrine and serotonin levels...
September 29, 2022: Scientific Reports
https://read.qxmd.com/read/36004739/the-norepinephrine-reuptake-inhibitor-reboxetine-alone-reduces-obstructive-sleep-apnea-severity-a-double-blind-placebo-controlled-randomized-crossover-trial
#32
RANDOMIZED CONTROLLED TRIAL
Thomas J Altree, Atqiya Aishah, Kelly A Loffler, Ronald R Grunstein, Danny J Eckert
STUDY OBJECTIVES: Recent findings indicate that noradrenergic and muscarinic processes are crucial for pharyngeal muscle control during sleep. However, to date, reductions in obstructive sleep apnea (OSA) severity have only been detected when noradrenergic agents are combined with an antimuscarinic. Accordingly, this study aimed to determine if reboxetine alone and combined with oxybutynin reduces OSA severity. The pathophysiological mechanisms underpinning the effects of these agents were also investigated via endotyping analysis...
January 1, 2023: Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine
https://read.qxmd.com/read/35977923/the-role-of-immunomodulators-in-treatment-resistant-depression-case-studies
#33
REVIEW
Charles W Beckett, Maria Victoria Niklison-Chirou
Depression is a common mental disorder affecting more than 264 million people worldwide. The first-line treatment for most cases of depression are selective serotonin reuptake inhibitors (SSRIs), such as sertraline, reboxetine and fluoxetine. Recently, it has been found that one-quarter of depressed patients have excessive activation of the immune system. This potentially warrants sub-categorisation of depressed patients into inflammatory and non-inflammatory subtypes. Such a sub-category of depression already exists for those not responding to various traditional antidepressants and is known as treatment-resistant depression...
August 17, 2022: Cell Death Discovery
https://read.qxmd.com/read/35866872/organocatalyzed-protecting-group-free-total-synthesis-of-s-s-and-s-r-reboxetine-an-antidepressant-drug
#34
JOURNAL ARTICLE
Ajay Sharma, Satyendra Kumar Pandey
An efficient, simple, and concise organocatalyzed protecting-group-free synthetic approach to the stereoisomers of the antidepressant drug reboxetine and its implementation toward the asymmetric synthesis of ( S,S )-reboxetine and ( S,R )-reboxetine from commercially available trans -cinnamaldehyde are described. The synthesis features organocatalytic Jørgensen asymmetric epoxidation, epoxide migration, and Mitsunobu inversion as key steps.
August 5, 2022: Journal of Organic Chemistry
https://read.qxmd.com/read/35771361/effect-of-single-doses-of-citalopram-and-reboxetine-on-urethral-pressure-a-randomized-double-blind-placebo-and-active-controlled-three-period-crossover-study-in-healthy-women
#35
JOURNAL ARTICLE
Thea Christoffersen, Jonatan Kornholt, Troels Riis, Jesper Sonne, David P Sonne, Niels Klarskov
AIMS: Urethral closure function is essential for urinary continence in women and decreased urethral pressure is associated with stress urinary incontinence (SUI). For decades, the effects of serotonergic drugs on central neural control of urethral closure have been investigated and discussed. Epidemiological studies suggest that the use of selective serotonin reuptake inhibitors (SSRIs), such as citalopram, is associated with SUI. However, the literature findings are conflicting. This study aimed to evaluate citalopram's effect on opening urethral pressure (OUP) in healthy women...
June 30, 2022: Neurourology and Urodynamics
https://read.qxmd.com/read/35761500/antidepressant-drugs-for-seizures-and-epilepsy-where-do-we-stand
#36
REVIEW
Martina Tallarico, Maria Pisano, Antonio Leo, Emilio Russo, Rita Citraro, Giovambattista De Sarro
People with epilepsy (PWE) are more likely to develop depression and both these complex chronic diseases greatly affect health-related quality of life (QOL). This comorbidity contributes to the deterioration of the QOL further than increasing the severity of epilepsy worsening prognosis. Strong scientific evidence suggests the presence of shared pathogenic mechanisms. The correct identification and management of these factors are crucial in order to improve patients' QOL. This review article discusses recent original research on the most common pathogenic mechanisms of depression in PWE and highlights the effects of antidepressant drugs (ADs) against seizures in PWE and animal models of seizures and epilepsy...
2023: Current Neuropharmacology
https://read.qxmd.com/read/35080494/simultaneous-brain-brainstem-and-spinal-cord-pharmacological-fmri-reveals-involvement-of-an-endogenous-opioid-network-in-attentional-analgesia
#37
JOURNAL ARTICLE
Valeria Oliva, Ron Hartley-Davies, Rosalyn Moran, Anthony E Pickering, Jonathan Cw Brooks
Pain perception is decreased by shifting attentional focus away from a threatening event. This attentional analgesia engages parallel descending control pathways from anterior cingulate (ACC) to locus coeruleus, and ACC to periaqueductal grey (PAG) - rostral ventromedial medulla (RVM), indicating possible roles for noradrenergic or opioidergic neuromodulators. To determine which pathway modulates nociceptive activity in humans, we used simultaneous whole brain-spinal cord pharmacological-fMRI (N = 39) across three sessions...
January 26, 2022: ELife
https://read.qxmd.com/read/34832993/influence-of-smallanthus-sonchifolius-yacon-on-the-activity-of-antidepressant-drugs-in-mice
#38
JOURNAL ARTICLE
Sylwia Wośko, Anna Serefko, Aleksandra Szopa, Sylwia Kardaś, Jarosław Widelski, Tomasz Mroczek, Ewelina Rostkowska, Jolanta Szymańska, Ewa Poleszak
Depression is one of the most common mental disorders in the world that negatively affects the daily functioning of patients. Numerous studies are currently being conducted to examine the antidepressant potential of innovative synthetic compounds and herbal substances. Yacon, Smallantchus sonchifolius , belongs to plants with numerous health-beneficial properties. Yacon-based products are regarded as a functional food. In our study, we attempted to check whether administration of Yacon tuber extract would have an antidepressant effect in the forced swim test (FST) in mice and whether its intake could influence the activity of conventional antidepressant drugs with different mechanisms of action, i...
October 21, 2021: Life
https://read.qxmd.com/read/34810289/toxic-effect-of-antidepressants-on-male-reproductive-system-cells-evaluation-of-possible-fertility-reduction-mechanism
#39
JOURNAL ARTICLE
P Solek, J Mytych, A Tabecka-Lonczynska, M Sowa-Kucma, M Koziorowski
Depression is acknowledged as a major public health problem. Pharmacological treatment may cause adverse drug reactions and sexual side effects. At the same time, the knowledge of the molecular mechanisms associated with antidepressant-mediated toxicity to reproductive cells is fragmentary. The aim of this study was the multilevel evaluation of the potential toxicity of several antidepressants or antipsychotic drugs (amitriptyline, 10 μM; escitalopram, 30 μM; fluoxetine, 5 μM; imipramine, 20 μM; mirtazapine, 150 μM; olanzapine, 40 μM; reboxetine, 30 μM; venlafaxine, 250 μM) on the cells of the spermatogenesis pathway...
June 2021: Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society
https://read.qxmd.com/read/34769286/molecular-consequences-of-depression-treatment-a-potential-in-vitro-mechanism-for-antidepressants-induced-reprotoxic-side-effects
#40
JOURNAL ARTICLE
Przemysław Sołek, Jennifer Mytych, Anna Tabęcka-Łonczyńska, Marek Koziorowski
The incidence of depression among humans is growing worldwide, and so is the use of antidepressants. However, our fundamental understanding regarding the mechanisms by which these drugs function and their off-target effects against human sexuality remains poorly defined. The present study aimed to determine their differential toxicity on mouse spermatogenic cells and provide mechanistic data of cell-specific response to antidepressant and neuroleptic drug treatment. To directly test reprotoxicity, the spermatogenic cells (GC-1 spg and GC-2 spd cells) were incubated for 48 and 96 h with amitriptyline (hydrochloride) (AMI), escitalopram (ESC), fluoxetine (hydrochloride) (FLU), imipramine (hydrochloride) (IMI), mirtazapine (MIR), olanzapine (OLZ), reboxetine (mesylate) (REB), and venlafaxine (hydrochloride) (VEN), and several cellular and biochemical features were assessed...
November 1, 2021: International Journal of Molecular Sciences
keyword
keyword
21770
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.